Medical News

RSS

Seattle conference to focus on trauma and addiction treatment

The incidence of trauma and abuse has truly reached epidemic proportions, and those who suffer trauma sometimes turn to alcohol or other drugs to manage post-traumatic stress symptoms like nightmares, anxiety, insomnia, and dissociation.

29 Sep 2012

Mount Sinai surgeon offers tips to prevent prostate cancer

World-renowned Mount Sinai robotic prostate surgeon, Dr. David Samadi, devotes much of his time to prostate cancer education domestically and internationally. "My SMART robotic prostate removal surgery saves lives, but what men really want to know is how to prevent prostate cancer in the first place," shares Dr. Samadi.

29 Sep 2012

FDA approves Boston Scientific’s S-ICD system to treat sudden cardiac arrest

The U.S. Food and Drug Administration has granted Boston Scientific Corporation regulatory approval for its S-ICD System, the world's first and only commercially available subcutaneous implantable defibrillator (S-ICD) for the treatment of patients at risk for sudden cardiac arrest (SCA).

29 Sep 2012

Health Employers Association of British Columbia, PAR-BC reach tentative agreement

A tentative agreement has been reached between the Professional Association of Residents of British Columbia (PAR-BC) and the Health Employers Association of British Columbia (HEABC).

29 Sep 2012

ConvaTec acquires 180 Medical

ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, announced today it has completed the acquisition of 180 Medical Holdings, Inc.

29 Sep 2012

GCE group, Dehaier partner to distribute EASE II products in China

Dehaier Medical Systems Ltd., an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced that it has signed a two-year distribution agreement with GCE group, a leading global compressed gas-equipment company, to become the exclusive distributor for GCE's EASE II products in Mainland China.

29 Sep 2012

New research on addiction mutual-support groups

Mutual-help groups for addiction have proliferated, diversified, and adapted to emerging substance-related trends over the past 75 years. A new special, triple issue of the Journal of Groups in Addiction & Recovery - Broadening the Base of Addiction Mutual Support: Bringing Theory and Science to Contemporary Trends - reviews the history of mutual-support groups for addiction that have arisen as adjuncts or alternatives to Twelve Step Programs.

29 Sep 2012

AVEO submits tivozanib NDA with FDA for treatment of advanced renal cell carcinoma

AVEO Oncology and Astellas Pharma Inc. today announced that AVEO has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for tivozanib in patients with advanced renal cell carcinoma (RCC).

29 Sep 2012

Screening practices for multidrug-resistant organisms in ICUs vary widely between hospitals

Screening practices for multidrug-resistant organisms (MDROs) in intensive care units (ICUs) vary widely from hospital to hospital, according to a new study published in the October issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).

29 Sep 2012

FDA approves Abbott’s HUMIRA to treat ulcerative colitis

Abbott today announced that the U.S. Food and Drug Administration (FDA) has approved HUMIRA (adalimumab) for inducing and sustaining clinical remission in adult patients with moderately to severely active ulcerative colitis (UC) when certain other medicines have not worked well enough.

29 Sep 2012

ACS honors world-leader in robotic prostate surgery with 2012 Community Partner Award

At last night's Annual Prostate Cancer Awareness and Education Dinner, the American Cancer Society awarded Dr. David B. Samadi, world-leader in prostate cancer treatment and robotic prostate surgery, with the 2012 Community Partner Award. Through robotic surgery excellence, Dr. Samadi has successfully cured more than 4,000 men of prostate cancer.

29 Sep 2012

EvaluatePharma’s new service focuses on medical device and diagnostic sector

EvaluatePharma, the premier source for life science sector analysis and consensus forecasts, today announced the launch of EvaluateMedTech, a new intelligence service focused on the medical device and diagnostic sector.

29 Sep 2012

Wage disparities could limit success of health-care reform

A national study has found that earnings over the course of the careers of primary-care physicians averaged as much as $2.8 million less than the earnings of their specialist colleagues, potentially making primary care a less attractive choice for medical school graduates and exacerbating the already significant shortage of medical generalists.

29 Sep 2012

Priority Health announces 2012 recipients of Senior Impact Awards

Priority Health is recognizing four regional winners with Senior Impact Awards. The awards program recognizes volunteers 63 years and older who devote their time and energy toward improving their communities. As part of this recognition, Priority Health awards a $1,000 donation to each winner's volunteer organization.

29 Sep 2012

1-800-Oncologist launches Contributing Expert program

1-800-Oncologist, Inc. announced today the launch of its Contributing Expert program for oncology and radiology specialists. Members of 1-800-Oncologist's national Contributing Expert network are key opinion leaders in the cancer field that help translate medical news into information patients can understand and act upon.

29 Sep 2012

Cameron Health receives FDA approval for subcutaneous implantable defibrillator system

The U.S. Food and Drug Administration today approved a heart defibrillator that helps to restore regular heart rhythms with leads that can be implanted just under the skin (subcutaneously) instead of connected directly into the heart.

29 Sep 2012

UBM Live announces finalists of CPhI Pharma Awards

Leading events organiser, UBM Live, announced the finalists of the CPhI Pharma Awards. Formerly known as the Innovation Awards, the rebranded CPhI Pharma Awards feature a gold, silver and bronze winner for the returning Best Pharma Innovation award.

29 Sep 2012

Collaborative Spine completes research agenda-setting process for spine care

The Collaborative Spine Research Foundation (Collaborative Spine) today announced it has completed the process of setting a research agenda for spine care. The agenda articulates the most critical clinical research issues that need to be addressed in order to deliver on the Foundation's commitment to advance the science and practice of the highest-quality spine care.

29 Sep 2012

Shengtai sales revenue increases 4.26% to $179,029,127 for fiscal year 2012

Shengtai Pharmaceutical, Inc., a manufacturer and distributor in China of glucose and starch as pharmaceutical raw materials and other starch and glucose products, today reported financial results for the twelve months ended June 30, 2012.

29 Sep 2012

FDA approves Globus Medical’s SECURE-C Cervical Artificial Disc

Globus Medical, Inc., today announced that the Food and Drug Administration (FDA) has granted Premarket Approval (PMA) for the SECURE-C Cervical Artificial Disc. Clinical data from a 380 patient investigational device exemption (IDE) study demonstrate that SECURE-C is statistically superior to anterior cervical discectomy and fusion (ACDF) in terms of overall success, subsequent surgery at the index level, device-related adverse events, and patient satisfaction at 24 months.

29 Sep 2012